Array ( )
Tergra (Sitagliptin) survey – Just another WordPress site

The scientific survey conducted is to evaluate the perspective and evolving recommendations related to insulin therapy in the treatment of Diabetes Mellitus.

Sign in

Steps to complete the survey:

1. Click on Sign In button and login using Mobile or Email OTP
2. Now, click on Participate button
3. Watch the entire video
4. Once the video ends, you will be redirected to the survey page
5. Fill in the survey and submit
6. Please fill out the bank details after submitting the survey

About the survey

Type 2 diabetes mellitus is a metabolic disease associated with low quality of life and early mortality. Diabetes treatment aims to prevent these outcomes by maintaining tight glycemic control and reducing cardiovascular risk factors.

Dipeptidyl peptidase 4 inhibitors are oral anti-diabetic drugs used to treat patients with type 2 diabetes mellitus by inhibiting the degradation of incretin peptides. The survey is intended to gather opinions from well-known diabetologists regarding the use of different dipeptidyl peptidase 4 inhibitors and the selection of appropriate therapies for best treatment outcomes in patients with type 2 diabetes.

Target Audience:

Diabetologists

Objectives:

1. To derive an unbiased approach in decision making and appropriate selection of therapy.

2. To collect unbiased valuable feedback from well-known diabetologists.

3. To provide clinical data to select appropriate therapeutic regimens and prioritize interventions in the management of type 2 diabetes mellitus.

4. To analyze results obtained from the survey and to address the topics of importance.